Towards Multi-Organoid Systems for Drug Screening Applications

Area of Science:

• Biotechnology
• Stem Cell Biology
• Drug Discovery

Background:

• High failure rate of drug candidates in development pipelines.
• Limitations of traditional animal models in predicting human responses.
• Need for advanced in vitro models for accurate drug screening.

Purpose of the Study:

• Review advancements in organoid generation from human pluripotent stem cells (hPSCs).
• Discuss the development and application of organ-on-a-chip devices.
• Highlight the potential for personalized medicine and improved drug discovery.

Main Methods:

• Generation of organoids from various cell lineages derived from hPSCs.
• Development of organ-on-a-chip systems for in vitro drug testing.
• Utilizing patient-specific induced pluripotent stem cells (hiPSCs) for personalized models.

Main Results:

• Organoid and organ-on-a-chip technologies show promise for reliable and rapid drug assessment.
• Patient-specific tissues derived from hiPSCs enable personalized drug screening.
• These models offer a more cost-effective alternative to animal testing.

Conclusions:

• Emerging organoid and organ-on-a-chip technologies are transforming drug discovery.
• These advanced in vitro models enhance the prediction of drug efficacy and toxicity.
• The integration of hPSC-derived organoids and microfluidic devices paves the way for personalized medicine.